HomeHNSA • STO
add
Hansa Biopharma AB
Previous close
kr 31.82
Day range
kr 31.04 - kr 33.18
Year range
kr 25.90 - kr 57.30
Market cap
2.17B SEK
Avg Volume
268.83K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 48.66M | 113.09% |
Operating expense | 154.21M | -25.98% |
Net income | -103.80M | 58.59% |
Net profit margin | -213.29 | 80.57% |
Earnings per share | -1.53 | 67.99% |
EBITDA | -116.22M | 42.34% |
Effective tax rate | -0.12% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 553.54M | -39.05% |
Total assets | 940.68M | -19.67% |
Total liabilities | 1.26B | 2.22% |
Total equity | -319.96M | — |
Shares outstanding | 67.81M | — |
Price to book | -6.74 | — |
Return on assets | -29.68% | — |
Return on capital | -41.91% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -103.80M | 58.59% |
Cash from operations | -148.80M | 22.85% |
Cash from investing | — | — |
Cash from financing | -1.89M | -5.17% |
Net change in cash | -151.46M | 22.07% |
Free cash flow | -101.33M | 28.35% |
About
Founded
2007
Website
Employees
135
